Patent · US Active

Pyrazine derivatives as CB2 receptor agonists

US9512141B2 · kind B2 · utility

6Cited by

0References

10Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Baledi Dhurwasulu · Darsi, IN
Uwe Grether · Weil am Rhein, DE
Matthias Nettekoven · Weil am Rhein, DE
Stephan Roever · Inzlingen, DE
Mark Rogers-Evans · Bottmingen, CH
Tanja Schulz-Gasch · Ziefen, CH

Key dates

Filing date	Dec 4, 2013
Grant date	Dec 6, 2016
Priority date	—
Expiry date	Dec 4, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 receptor agonist for use in the treatment of several disorders, such as pain, atherosclerosis and glaucoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.